Therefore, antagonism of mGlu5 may reduce excessive glutamate transmission throughout the basal ganglia structures implicated in the symptoms of PD, while avoiding adverse effects of ionotropic glutamate receptor antagonists. Here, GRM5 is linked to Parkinson disease.